SCHMC

A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer

Metadata Downloads
All Author(s)
S. H. Lim ; J. Yun ; M. Y. Lee ; H. J. Kim ; K. H. Kim ; S. H. Kim ; S. C. Lee ; S. B. Bae ; C. K. Kim ; N. Lee ; K. T. Lee ; S. K. Park ; D. S. Hong ; H. J. Choi ; J. H. Moon
Intsitutional Author(s)
김한조; 이상철; 배상병; 이규택
Issued Date
2018
Type
Conference
Conference Name
Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)
Conference Date
43118
dc_citation_conferenceCountry
San Francisco, CA, United States
Citation Publisher
American Society of Clinical Oncology
Citation Title
Journal of Clinical Oncology. Volume 36, Number 4_suppl
Citation Start Page
344
Citation End Page
344
Language(ISO)
eng
DOI
10.1200/JCO.2018.36.4_suppl.344
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/4540
Appears in Collections:
종양혈액내과 > 2. Conference Papers
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.